Omnicell, Inc. announced its financial results for the quarter ended March 31, 2024 and plans to wind down its Medimat Robotic Dispensing System (RDS) product line, resulting in nonrecurring charges of $15 - $20 million.
AI Assistant
OMNICELL INC
2024
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.